Trial Condition(s):

Hypertension, Postmenopause

Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive Women

Bayer Identifier:

91202

ClinicalTrials.gov Identifier:

NCT00102141

EudraCT Number:

Not Available

Study Completed

Trial Purpose

The objective of the study is to evaluate the effects of Angeliq on BP over a period of 8 weeks in postmenopausal women who may benefit from hormone replacement therapy (HRT) for the relief of vasomotor symptoms and who have hypertension.

Inclusion Criteria
:- Have hypertension- Are currently taking antihypertensive medications- Have had natural menopause at least 1 year prior to screening- Must require hormone therapy in the opinion of the investigator
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
750
Trial Dates
black-arrow
Phase
3
Could I receive a placebo?
Yes
Products
Angeliq (E2/DRSP, BAY86-4891)
Accepts Healthy Volunteers
No

Where to Participate

Locations
Status
LocationsStatus

Trial Design